| Ident. | Authors (with country if any) | Title |
|---|
| 000155 (2015) |
Christopher F. O'Brien [États-Unis] ; Roland Jimenez [États-Unis] ; Robert A. Hauser [États-Unis] ; Stewart A. Factor [États-Unis] ; Joshua Burke [États-Unis] ; Daniel Mandri [États-Unis] ; Julio C. Castro-Gayol [États-Unis] | NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study. |
| 000194 (2015) |
Hubert H. Fernandez [États-Unis] ; David G. Standaert ; Robert A. Hauser ; Anthony E. Lang ; Victor S C. Fung ; Fabian Klostermann ; Mark F. Lew ; Per Odin ; Malcolm Steiger ; Eduard Z. Yakupov ; Sylvain Chouinard ; Oksana Suchowersky ; Jordan Dubow ; Coleen M. Hall ; Krai Chatamra ; Weining Z. Robieson ; Janet A. Benesh ; Alberto J. Espay | Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. |
| 000249 (2015) |
Werner Poewe [Autriche] ; Robert A. Hauser ; Anthony Lang | Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS. |
| 000258 (2015) |
Robert A. Hauser [États-Unis] ; Stuart Isaacson ; Jerome P. Lisk ; L Arthur Hewitt ; Gerry Rowse | Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). |
| 000325 (2015) |
Rajesh Pahwa [États-Unis] ; Caroline M. Tanner [États-Unis] ; Robert A. Hauser [États-Unis] ; Kapil Sethi [États-Unis] ; Stuart Isaacson [États-Unis] ; Daniel Truong [États-Unis] ; Lynn Struck [États-Unis] ; April E. Ruby [États-Unis] ; Natalie L. Mcclure [États-Unis] ; Gregory T. Went [États-Unis] ; Mary Jean Stempien [États-Unis] | Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study). |
| 000455 (2014) |
Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart Isaacson | Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. |
| 000486 (2014) |
Samuel M. Goldman [États-Unis] ; Freya Kamel ; G Webster Ross ; Sarah A. Jewell ; Connie Marras ; Jane A. Hoppin ; David M. Umbach ; Grace S. Bhudhikanok ; Cheryl Meng ; Monica Korell ; Kathleen Comyns ; Robert A. Hauser ; Joseph Jankovic [États-Unis] ; Stewart A. Factor ; Susan Bressman ; Kelly E. Lyons ; Dale P. Sandler ; J William Langston ; Caroline M. Tanner | Peptidoglycan recognition protein genes and risk of Parkinson's disease. |
| 000613 (2014) |
Peter A. Lewitt [États-Unis] ; F Jacob Huff ; Robert A. Hauser ; Dan Chen ; Dmitri Lissin ; Katie Zomorodi ; Kenneth C. Cundy | Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease. |
| 000720 (2013) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins ; Kathryn A. Chung ; Robert A. Hauser ; Janis M. Miyasaki ; Anthony P. Nicholas ; Werner Poewe [Autriche] ; Klaus Seppi ; Olivier Rascol ; Mark A. Stacy ; John G. Nutt ; Caroline M. Tanner ; Alison Urkowitz ; Jean A. Jaglin ; Song Ge | Which dyskinesia scale best detects treatment response? |
| 000943 (2013) |
Stewart A. Factor [États-Unis] ; Kenneth Wolski ; Daniel M. Togasaki ; Susan Huyck ; Marc Cantillon ; T W Ho ; Robert A. Hauser ; Emmanuelle Pourcher | Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. |
| 000B34 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 001182 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Serge V. Van De Witte ; And Ad Theeuwes | Pardoprunox in early Parkinson's disease: results from 2 large, randomized double-blind trials. |
| 001381 (2011) |
Robert A. Hauser [États-Unis] ; Peggy Auinger | Determination of minimal clinically important change in early and advanced Parkinson's disease. |
| 001394 (2011) |
Robert A. Hauser [États-Unis] ; Aaron L. Ellenbogen ; Leo Verhagen Metman ; Ann Hsu ; Martin J. O'Connell ; Nishit B. Modi ; Hsuan-Ming Yao ; Sherron H. Kell ; Suneel K. Gupta | Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease. |
| 001584 (2010) |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín ; Giovanni Fabbrini ; Robert A. Hauser ; Marcelo Merello ; Janis Miyasaki ; Werner Poewe [Autriche] ; Cristina Sampaio ; Olivier Rascol ; Glenn T. Stebbins ; Anette Schrag ; Christopher G. Goetz | Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations. |
| 001666 (2010) |
Robert A. Hauser [États-Unis] ; Anthony H V. Schapira ; Olivier Rascol ; Paolo Barone ; Yoshikuni Mizuno ; Laurence Salin ; Monika Haaksma ; Nolwenn Juhel ; Werner Poewe [Autriche] | Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. |
| 001735 (2010) |
Ray L. Watts [États-Unis] ; Kelly E. Lyons ; Rajesh Pahwa ; Kapil Sethi ; Matthew Stern ; Robert A. Hauser ; Warren Olanow ; Alex M. Gray ; Bryan Adams ; Nancy L. Earl | Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. |
| 001911 (2010) |
Olivier Rascol [France] ; Paolo Barone ; Robert A. Hauser ; Yoshikuni Mizuno ; Werner Poewe [Autriche] ; Anthony H V. Schapira ; Laurence Salin ; Mandy Sohr ; Catherine Debieuvre | Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. |
| 001917 (2010) |
Bonnie P. Hersh [États-Unis] ; Nancy L. Earl ; Robert A. Hauser ; Mark Stacy | Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations. |
| 001925 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Ad Theeuwes ; Serge V. Van De Witte ; Guus Van Scharrenburg | Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease. |
| 001C06 (2009) |
Robert A. Hauser [États-Unis] ; Kelly E. Lyons ; Terry Mcclain ; Summer Carter ; David Perlmutter | Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. |
